Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Signal., 15 January 2013
Vol. 6, Issue 258, p. rs3
[DOI: 10.1126/scisignal.2003305]

RESEARCH RESOURCES

Editor's Summary

Screening for Inflammation
NOD2 is a cytoplasmic pattern recognition receptor that detects bacterial peptidoglycan fragments and stimulates antimicrobial and proinflammatory immune responses through activation of mitogen-activated protein kinases and the transcription factor NF-{kappa}B, respectively. Loss- and gain-of-function mutations in the gene encoding NOD2 are associated with inflammatory disorders, including Crohn’s disease. Warner et al. performed a small interfering RNA screen to look for positive and negative regulators of NOD2 signaling in HEK 293 cells and validated some of their candidates in murine macrophages. In addition to identifying previously implicated mediators of NOD2 signaling, the screen identified previously uncharacterized regulators of NOD2 that interacted with core components of the NF-{kappa}B pathway. Together, these data suggest potential candidates that may be associated with Crohn’s disease.

Citation: N. Warner, A. Burberry, L. Franchi, Y.-G. Kim, C. McDonald, M. A. Sartor, G. Núñez, A Genome-Wide siRNA Screen Reveals Positive and Negative Regulators of the NOD2 and NF-{kappa}B Signaling Pathways. Sci. Signal. 6, rs3 (2013).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Science Signaling Podcast: 15 January 2013.
G. Nunez and A. M. VanHook (2013)
Science Signaling 6, pc2
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882